Navigation Links
Chimerix to Present at 9th Annual BIO Investor Forum
Date:9/28/2010

RESEARCH TRIANGLE PARK, N.C., Sept. 28 /PRNewswire/ -- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch, President and Chief Executive Officer, will present a corporate overview at the upcoming BIO Investor Forum Conference on October 5th, 2010 at 2:00pm PT.  The conference is being held at the Palace Hotel in San Francisco, California.

Mr. Moch will discuss the company's antiviral pipeline and technology assets, including CMX001, a broad spectrum antiviral in clinical development for the treatment of double-stranded DNA viruses such as cytomegalovirus, adenovirus, BK virus, JC virus, Epstein-Barr virus and herpes simplex virus; and CMX157, being developed as a potential once-weekly nucleoside analogue against HIV infections.

The BIO Investor Forum is a conference for international investors focused on private and emerging public biotechnology companies.  In an effort to support industry-wide success, the conference presents a broad and unbiased view of investment opportunities with the support of physicians, scientists, and industry analysts.  

About Chimerix

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health.  The company's lead candidate, CMX001, is in Phase 1 and Phase 2 clinical studies in immunocompromised transplant and cancer patients for the treatment of life-threatening viruses, such as BK virus, cytomegalovirus and adenovirus.  CMX001 is also being developed as a biodefense countermeasure in the event of a smallpox release.  Chimerix has advanced a second antiviral compound, CMX157, into Phase 1 clinical studies as a potent nucleoside analogue against multi-drug resistant HIV infections.  Led by a world-class antiviral drug development team, Chimerix is also leveraging th
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
2. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
3. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
4. Chimerix to Present at Two Upcoming Investor Conferences
5. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
6. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
7. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
8. Delcath to Present at the William Blair Emerging Growth Stock Conference
9. China-Biotics to Present at Jefferies Healthcare Conference
10. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
11. Data from Multiple Clinical Trials of OrbusNeichs Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015  Epic Sciences announced today that ... from metastatic castrate resistant prostate cancer patients, at ... for Clinical Oncology. This application expands the investigational ... behind™ platform to characterize circulating tumor cell ... stage patients have heterogeneous clonal CTC populations harboring ...
(Date:5/29/2015)... THOUSAND OAKS, Calif. , May 29, 2015 ... announced pooled data from two pivotal Phase 3, ... novel calcimimetic, for the treatment of secondary hyperparathyroidism ... receiving hemodialysis. Both studies met the primary endpoint, ... the AMG 416 groups achieved a greater than ...
(Date:5/29/2015)... MALVERN, Pa. , May 29, 2015 /PRNewswire-USNewswire/ ... major focus of the Association for the Advancement ... 1995. With support from AAWC,s corporate ... Educational Portal on the AAWC website ... on a wound care pathway with links to ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7The Association for the Advancement of Wound Care Educates the Public 2
... Hospital one of 18 centers involved in 10-year study, ... study,published in the August 28 issue of the New ... women delivering before 32,weeks of gestation reduced the risk ... Antenatal Magnesium Sulfate (BEAM) trial was,conducted in 18 centers ...
... Team Makes Crucial Breakthrough in Battle to Prevent ... Onset of Parkinson,s Disease, ... that scientists at The University of Nottingham,have made a crucial breakthrough ... common type of dementia and Parkinson,s disease., The researchers have ...
Cached Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... within USA Today, with a circulation of approximately 250,000 ... is distributed nationally, through a vast social media strategy, ... partner outlets. To explore the digital version of the ... the cover of the print publication. Inside, the actress, ...
(Date:5/29/2015)... The campaign focuses on the overall topic ... specific concerns within, including the importance of early intervention ... the workplace. We are encouraged to re-think the ways ... special focus to people living with bipolar disorder and ... help from healthcare professionals and their overall community. ...
(Date:5/29/2015)... 29, 2015 Healthpointe is now ... specialists, physical therapy, and injections , For patients ... and/or lower back pain, Healthpointe has a team ... herniated discs, disc protrusions and other causes of ... Healthpointe’s team of renowned surgeons are now treating ...
(Date:5/29/2015)... Dallas, Texas (PRWEB) May 29, 2015 ... a professional and in-depth study on the current ... figures the report provides key statistics on the ... source of guidance and direction for companies and ... a basic overview of the industry including definitions, ...
(Date:5/29/2015)... Florida (PRWEB) May 29, 2015 Designed ... Bodybuilding.com teamed up to create an all new, exclusive ... are a formulated with the latest and greatest, high ... and proven to be effective. The 24/7 Series can ... to cross-fitters and even the casual fitness enthusiasts. There ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3
... India has decided to prepare a set of guidelines ... standard quality (NSQ) medical devices, diagnostic reagents, diagnostic kits ... procedures to be followed and action to be taken ... ,Officials say the current move is to make ...
... Researchers from University of Texas Medical Branch at Galveston ... that may cause the allergic reactions// and asthma other ... ,This factor is the damage caused by chemically ... spawned by interactions between a single pollen-carried enzyme and ...
... common talk both in medical circles as well as social ... ,Therefore any news with respite from that is always welcome. ... linked to the insulin resistance syndrome among young obese adults. ... dairy intake may reduce the risk of type 2 diabetes ...
... have solved the structure of a critical piece of ... will help treat cardiac or neurological diseases//. ,Biologist Dale ... the structure of synapse-associated protein 97 (SAP97) found in ... www.brown.edu. ,This protein is believed to play a ...
... home can be of a grave nature and seems to ... ,Researchers at Cincinnati Children's Hospital Medical Center who had reported ... said that preventable injuries sustained at home account for more ... the results taken from the National Vital Statistics System Mortality ...
... Andhra Pradesh Chief Minister Y.S. Rajasekhara Reddy Saturday administered ... effort to create awareness on HIV/AIDS,. ,India has ... the highest prevalence of HIV cases in the country ... National AIDS Control Organization (NACO), the HIV prevalence rate ...
Cached Medicine News:Health News:Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices 2Health News:New Insight Gained For Allergic Reactions 2Health News:"Defeat AIDS Pledge" by Andhra CM 2
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves....
... range of fixed curve catheters designed to ... and other patients with small anatomies. Each ... only the finest materials. A unique multi-step ... extrusion technologies results in the excellent torque ...
... To aid clinicians in performing Ankle/Brachial Index ... new, complete packet of information. It includes ... that can be viewed on any computer ... step-by-step procedure of performing an ABI test, ...
... VERICIS PhysioLog Hemodynamic Monitoring and Data ... system for the cath lab, integrating ... Waveform analysis , Data collection , ... Image capture/analysis , Procedural reporting ...
Medicine Products: